labetalol has been researched along with propranolol in 217 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 131 (60.37) | 18.7374 |
| 1990's | 27 (12.44) | 18.2507 |
| 2000's | 22 (10.14) | 29.6817 |
| 2010's | 33 (15.21) | 24.3611 |
| 2020's | 4 (1.84) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Faller, B; Wohnsland, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Baker, JG | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Akamatsu, M | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Thorling, CA; Zhang, Q | 1 |
| Chavatte, P; Dubois, J; Farce, A; Furman, C; Gilleron, P; Hénichart, JP; Le Broc-Ryckewaert, D; Lemoine, A; Millet, R; Pommery, N; Wlodarczyk, N | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Buckley, DB; Funk, RS; Hensley, T; Kazmi, F; Loewen, GJ; Parkinson, A; Pope, C | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alam, MA; Drewes, LR; Gurrapu, S; Jonnalagadda, SK; Lueth, EA; Mereddy, VR; Nelson, GL; Ronayne, CT; Solano, LN | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Abouf, M; Abutaleb, NS; Chen, L; Elsebaei, MM; Ghiaty, A; Hegazy, YA; Malwal, SR; Mayhoub, AS; Mohammad, H; Oldfield, E; Seleem, MN; Zhang, J | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Brittain, RT; Levy, GP | 1 |
| Brown, JJ; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM | 4 |
| Wilcox, RG | 1 |
| Dobbs, RJ; Prichard, BN; Richards, DA | 1 |
| Hobson, JD; Jauernig, RA; Moulds, RF; Shaw, J | 1 |
| Hashimoto, K; Hashimoto, T; Iizuka, H; Imai, S; Matsuda, H; Tsukada, T | 1 |
| Sommers, DK | 3 |
| Carey, B; Whalley, ET | 1 |
| Nencini, P | 1 |
| Gaddie, J; Palmer, KN; Skinner, C | 1 |
| Kennedy, I; Levy, GP | 1 |
| Armstrong, BK; Beilin, L; Nassim, M; Pugsley, DJ | 1 |
| Cooper, R; Gear, JS; Ledingham, JG; Steiner, JA | 1 |
| Allonen, H; Kleimola, T; Lehtonen, A | 1 |
| Nyberg, G; Vedin, A; Wilhelmsson, C | 1 |
| Anstad, U; Lote, K; Nordøy, A; Svenson, B | 1 |
| Armstrong, BK; Beilin, LJ; Nassim, MA; Pugsley, DJ | 1 |
| Boakes, AJ; Joekes, AM; Prichard, BN; Thompson, FO | 1 |
| Maconochie, JG; Richards, DA; Woodings, EP | 3 |
| Armstrong, B; Beilin, LJ; Nassim, M; Pugsley, D | 1 |
| Blankesteijn, WM; Graafsma, SJ; Hectors, MP; Olde Riekerink, EA; Rodrigues de Miranda, JF; Thien, T | 1 |
| Goldberg, SR; Schindler, CW; Tella, SR | 1 |
| Demopoulos, CA; Kapoulas, VM; Tsangaris, GT; Tsoukatos, DC | 1 |
| Cattaneo, BM; Giannattasio, C; Grassi, G; Mancia, G; Perondi, R; Seravalle, G; Zanchetti, A | 1 |
| Boer, GJ; Botterblom, MH; De Barrios, J; Erdtsieck-Ernste, EB; Feenstra, MG | 1 |
| Mills, RG; Roberts, MS; Shen, JJ; Wanwimolruk, S | 1 |
| Latini, R; Mennini, T; Riva, E | 1 |
| Kato, T; Kinjo, N; Moromizato, H; Noguchi, K; Sakanashi, M | 1 |
| Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T | 1 |
| Bilić, A; Ljubicić, N | 1 |
| Nakajima, M; Ueda, M | 1 |
| Richardson, SB; Twente, S | 1 |
| Davidson, JM; Maurice, J; Richardson, R; Smith, ER; Walter, T | 1 |
| Hall, WD; Hirsch, A; Massie, B; Porter, V; Szlachcic, J; Tubau, JF; Vollmer, C; Wollam, G | 1 |
| Davies, G; Hyer, SL; Kohner, EM; Mackay, EM; VandenBurg, MJ | 1 |
| Døssing, M; Hamberg, O; Loft, S; Olesen, KL; Sonne, J; Thyssen, H; Victor, MA; Vollmer-Larsen, A | 1 |
| Babov, KD; Il'iash, MG; Kravtsova, LA; Shcherbak, IaIu | 1 |
| Louis, WJ; Rand, MJ; Story, DF; Tung, LH | 1 |
| Antonellis, A; Pula, K; Rivelli, M; Sybertz, EJ; Watkins, RW | 2 |
| Cronin, CJ; Graham, BR; Prichard, BN; Tomlinson, B | 1 |
| Dangman, KH; Zaim, S | 1 |
| Bertora, PL; Bevilacqua, M; Bosisio, E; Chebat, E; Norbiato, G; Sardina, M; Savonitto, S | 1 |
| Cleroux, J; Giannattasio, C; Grassi, G; Mancia, G; Seravalle, G; Zanchetti, A | 1 |
| Bedsole, GD; Cubbon, J; Davidov, ME; Frishman, WH; Gorwit, J; Michelson, EL; Poland, MP; Schoenberger, JA; Wallin, JD | 1 |
| Charlap, S; Frishman, WH; Shapiro, W | 1 |
| Davidov, ME; Frishman, WH; Gorwit, JI; Michelson, EL; Poland, MP; Schoenberger, JA; Wallin, JD | 1 |
| Davies, G; Hyer, SL; Kohner, EM; Mackay, EM; Vanden Burg, MJ | 1 |
| Atwood, J; Walsh, M | 1 |
| Aisa, L; Pelegrí, A; Reguant, M; Romero, R | 1 |
| Carr, ME; Cubeddu, LX; Fuenmayor, NJ | 1 |
| Rietbrock, N; Woodcock, BG | 1 |
| Harron, DW; Riddell, JG; Shanks, RG | 1 |
| Honda, K; Miyata-Osawa, A; Nakagawa, C; Shiono, K; Takenaka, T | 1 |
| Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 2 |
| Lepäntalo, M | 2 |
| Matsunaga, K; Nakamura, K; Ueda, M | 1 |
| Fishbein, L; Jackson, CD | 1 |
| Smirnov, GB | 1 |
| Epstein, M; Oster, JR | 1 |
| Kanno, M; Nakaya, H; Tohse, N | 1 |
| Maddox, YT; Mostaghim, R; Ramwell, PW | 1 |
| Kreutner, W; Rizzo, C | 1 |
| Bernini, F; Cighetti, G; Corsini, A; Fumagalli, R; Galli, G; Soma, M | 1 |
| Clerici, C; Harf, A; Macquin-Mavier, I | 1 |
| Pandhi, P; Sharma, PL | 1 |
| Fujimoto, T; Fujita, E; Hazu, R; Iwasaki, Y; Nagasaka, Y; Nakajima, S; Tanaka, A; Touda, Y; Tsuya, Y; Uenishi, H | 1 |
| Proegler, M; Schneider, H | 1 |
| Viinikka, L; Ylikorkala, O | 1 |
| Sharaeva, ML; Zaĭtseva, VI | 1 |
| Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B | 1 |
| Hashimoto, T; Kaguchi, Y; Kimura, M; Kuriyama, S; Miyahara, T; Nakamura, K; Tamai, K; Tamura, H | 1 |
| Ivanova, DK; Mironova, OV; Shkliar, LV; Sirenko, IuN | 1 |
| Colditz, GA; Delea, TE; Huse, DM; Oster, G; Savage, DD | 1 |
| Ayuso Gatell, A; Martínez Ferrer, JR; Pujol Colomer, J; Trenchs Verdaguer, X | 1 |
| Curry, C; Hinds, J; Kong, BW; Medakovic, M; Poland, M; Roper, K; Saunders, E | 1 |
| Armario, A; Garvey, JS; Hidalgo, J | 1 |
| Mrakovcić, I; Pahor, D; Polić, L; Radosević-Stasić, B; Rukavina, D | 1 |
| Glogar, DH | 1 |
| Pandhi, P; Sharma, BK; Sharma, PL; Wahi, PL | 1 |
| Matsumura, Y; Morimoto, S | 1 |
| Kameda, H | 1 |
| Banim, SO; Butrous, GS; Camm, AJ; Maltz, MB; O'Keefe, J | 1 |
| Lepäntalo, M; Lindström, BL; Tötterman, KJ | 1 |
| Berry, DA; Finley, D; Holtzman, JL; Johnson, B; Sirgo, MA | 1 |
| Due, DL; Giguere, GC; Plachetka, JR | 1 |
| Seal, DV | 1 |
| Aslam, S; Pandhi, P; Sharma, BK; Sharma, PL; Wahi, PL | 1 |
| Flamenbaum, W | 1 |
| Burford, JG; Chetty, K; Conrad, SA; George, RB; Hudson, LD; Light, RW; Manocha, K | 1 |
| Carr, AA; Flamenbaum, W; Materson, BJ; McMahon, FG; Poland, M; Weber, MA | 1 |
| Calder, AA; Forbes, CD; Greer, IA; Walker, JJ | 1 |
| ten Berge, BS; van der Veur, E; Wesseling, H; Wouda, AA | 1 |
| Burris, JF | 1 |
| Giorgetti, F; Re, L; Rossini, L | 1 |
| Re, L; Rossini, L | 1 |
| Larsson, K | 1 |
| Clifton, JE; Collins, I; Hallett, P; Hartley, D; Lunts, LH; Wicks, PD | 1 |
| Carlsen, JE; Christensen, NJ; Hartling, OJ; Svendsen, TL; Tangø, M; Trap-Jensen, J | 1 |
| Adam, WR; Barter, CE; Meagher, EJ | 1 |
| Charyev, KhE; Erina, EV | 1 |
| Desiatnichenko, VM; Romakov, AIu; Sagirov, AM; Sobol', IuS; Sumarokov, AB | 1 |
| Bengtsson, C | 1 |
| Coote, JH; Kubik, MM | 1 |
| Johns, VJ | 1 |
| Cherenshchikova, EA; Filippov, AK; Iuzhakov, SD; Mashkovskiĭ, MD; Porotikov, VI | 1 |
| Bamonte, F; Forlani, A; Monopoli, A; Ongini, E; Parravicini, L | 1 |
| Abiko, Y; Hosaka, A; Kogure, H | 1 |
| Ahuja, RC; Nelson, GI; Silke, B; Taylor, SH | 2 |
| Anand, MP; Dattani, KK; Doshi, BS; Kulkarni, RD | 2 |
| Anand, MP; Datey, KK; Dattani, KK | 1 |
| Ahuja, RC; Nelson, GI; Silke, B; Taylor, SH; Walker, C | 1 |
| Borthwick, JM; Jones, RM; Lovelock, HA; Pollard, BJ; Rowbottom, SJ | 1 |
| Doyle, AE | 1 |
| Clanachan, AS; Forbes, R; Moonie, GT | 1 |
| Ahuja, RC; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH | 1 |
| Krug, H; Ochotny, R; Poprawski, K | 1 |
| Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 1 |
| Bauer, GE; Hunyor, SN; Larkin, H; Ross, M | 1 |
| Bjurö, T; Hagman, M; Nyberg, G; Smith, U | 1 |
| Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T | 1 |
| Berglund, G; Nyberg, G | 1 |
| Bulpitt, CJ; Butler, AG; Husaini, MH; Nicholls, DP; Stephens, MD | 1 |
| Chalmers, JP; Graham, JR; Grygiel, JJ; Mulligan, J; Walkley, J; West, MJ; Wing, LM | 1 |
| Donker, AJ; May, JF; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
| Ambrosioni, E; Magnani, B; Malini, PL; Negroni, S; Strocchi, E | 1 |
| Daneshmend, TK; Roberts, CJ | 1 |
| Gomez, G | 1 |
| Agabiti-Rosei, E; Alicandri, CL; Beschi, M; Boni, E; Castellano, M; Fariello, R; Montini, E; Muiesan, G; Romanelli, G; Zaninelli, A | 1 |
| Agabiti-Rosei, E; Alicandri, C; Beschi, M; Boni, E; Castellano, M; Fariello, R; Muiesan, G; Muiesan, ML; Romanelli, G | 1 |
| Kogure, H | 1 |
| Colombo, G; Fea, F; Foti, F; Pelliccioli, I; Planca, E; Salvioli, G | 1 |
| Berg, KJ; Walstad, RA; Wessel-Aas, T | 1 |
| Riley, AJ; Riley, EJ | 1 |
| Larsen, JS; Pedersen, EB | 2 |
| Harvald, B | 1 |
| Chew, SL; Grossman, AB; Sheaves, R | 1 |
| Cho, CH; Yat, PC | 1 |
| Annane, D; Bellissant, E; Giudicelli, JF; Thuillez, C | 1 |
| Janssen, BJ; Oosting, J; Struyker-Boudier, HA; Tyssen, CM | 1 |
| Arner, P; Galitzky, J; Lafontan, M; Nordenström, J | 1 |
| Botterblom, MH; Erdtsieck-Ernste, EB; Feenstra, MG | 1 |
| Kemp, GJ; Odoom, JE; Radda, GK | 1 |
| Kilár, F | 1 |
| Carrupt, PA; Cheymol, G; Levron, JC; Poirier, JM; Snoeck, E; Testa, B; Weissenburger, J | 1 |
| Cho, CH; Kaan, SK | 1 |
| Brocher, N; Copeland, A; Godfrey, J; Thornton, H; Wilson, C | 1 |
| Lind, L; Millgård, J; von zur Můhlen, B | 1 |
| Chen, IJ; Chiang, LC; Chiu, CC; Liang, JC; Lin, YT; Tsai, CH; Wu, JR; Yeh, JL | 1 |
| Enlow, B; Howell, JM; Klein-Schwartz, W; Litovitz, TL; Love, JN | 1 |
| Dupont, S; Mallefet, J; Vanderlinden, C | 1 |
| Accinni, R; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S | 1 |
| Asadpour-Zeynali, K; Jouyban, A; Majidi, MR | 1 |
| Campisi, J; Fleshner, M; Greenwood, BN; Johnson, JD; Kennedy, SL; Nickerson, M; Sharkey, CM | 1 |
| Arima, Y; Hasegawa, C; Izawa, H; Kumazawa, T; Lee, XP; Sato, K; Umezawa, H | 1 |
| Ikonen, M; Kontturi, K; Murtomäki, L | 1 |
| Bao, J; Johnson, PE; Krylov, SN; Krylova, SM; Reinstein, O; Wilson, DJ | 1 |
| Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q | 1 |
| Tohda, Y | 1 |
| Harken, AH | 1 |
| Bagcivan, I; Berkan, O; Göksel, S; Korkmaz, O; Saraç, B; Yildirim, S | 1 |
| Alawi, KM; Aubdool, AA; Brain, SD; Keeble, JE; Liang, L; Psefteli, MP; Vepa, A; Wilde, E | 1 |
| Chen, W; Duan, L; Lee, MS; Ng, A; Nguyen, J; Shen, AY; Spencer, HT | 1 |
| Madias, JE | 1 |
| Tornvall, P; Y-Hassan, S | 1 |
| Badaoui, M; Dickson, CJ; Hornak, V; Kells, A; Molteni, C; Rosta, E | 1 |
| Chen, W; Duan, L; Lee, MS; Ng, A; Spencer, HT | 1 |
| Dingle, LMK; Edkins, AL; Veale, CGL; Weyers, C; Wilhelmi, BS | 1 |
| Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
9 review(s) available for labetalol and propranolol
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Autonomic Fibers, Preganglionic; Desoxycorticosterone; Dogs; Electric Stimulation; Ethanolamines; Guinea Pigs; Hemodynamics; Hypertension; Hypertension, Renal; In Vitro Techniques; Isoproterenol; Labetalol; Male; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Phentolamine; Phenylephrine; Propranolol; Rabbits; Rats | 1976 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta blockers and renal function: a reappraisal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Urea Nitrogen; Cardiac Output; Creatinine; Dogs; Glomerular Filtration Rate; Heart; Humans; Hypertension; Kidney; Labetalol; Metoprolol; Nadolol; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance | 1985 |
Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
Topics: Aged; Black People; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol | 1987 |
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Coronary Disease; Dogs; Heart Rate; Humans; Hypertension; Labetalol; Myocardial Infarction; Propranolol | 1984 |
Hypertension and calcium antagonists.
Topics: Airway Resistance; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Labetalol; Pindolol; Propranolol; Verapamil | 1982 |
[My research on asthma today and in the future].
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Humans; Interleukin-4; Labetalol; Lymphocytes; Phosphoric Diester Hydrolases; Propranolol; Receptors, GABA; Receptors, Muscarinic; Theophylline; Thiadiazoles | 2013 |
63 trial(s) available for labetalol and propranolol
| Article | Year |
|---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Asthma; Bronchi; Clinical Trials as Topic; Constriction; Ethanolamines; Female; Heart Rate; Humans; Injections, Intravenous; Labetalol; Male; Middle Aged; Placebos; Propranolol; Pulse; Respiration; Spirometry | 1975 |
A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol; Time Factors | 1979 |
Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Raynaud Disease; Skin Temperature | 1979 |
Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
Topics: Adult; Dihydralazine; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol; Time Factors | 1979 |
Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.
Topics: Adult; Blood Pressure; Ethanolamines; Fatigue; Heart Rate; Humans; Isometric Contraction; Labetalol; Male; Physical Exertion; Propranolol; Rest | 1979 |
The effects of a combined alpha- and beta-blocking drug, labetalol, on some aspects of platelet function.
Topics: Adult; Blood Platelets; Blood Pressure; Ethanolamines; Female; Humans; Labetalol; Male; Middle Aged; Platelet Aggregation; Platelet Factor 3; Propranolol | 1978 |
Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Topics: Adult; Antibodies, Antinuclear; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as Topic; Diuretics; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Pulse; Time Factors | 1976 |
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Heart Rate; Humans; Hypertension; Injections, Intravenous; Labetalol; Propranolol | 1976 |
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Diazoxide; Drug Therapy, Combination; Ethanolamines; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Physical Exertion; Posture; Propranolol | 1975 |
Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.
Topics: Adult; Blood Pressure; Ethanolamines; Heart Rate; Humans; Labetalol; Male; Peak Expiratory Flow Rate; Physical Exertion; Propranolol; Time Factors | 1977 |
Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects.
Topics: Adult; Blood Pressure; Bronchi; Drug Interactions; Ethanolamines; Forced Expiratory Volume; Histamine; Humans; Labetalol; Male; Propranolol; Pulse | 1977 |
Modification of pressor responses induced by 'cold' [proceedings].
Topics: Adult; Blood Pressure; Cardiac Output; Cold Temperature; Heart Rate; Humans; Labetalol; Male; Phentolamine; Propranolol | 1977 |
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
Topics: Aldosterone; Angiotensin II; Depression, Chemical; Ethanolamines; Heart Rate; Humans; Hypertension; Labetalol; Propranolol | 1976 |
Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo.
Topics: Adult; Aged; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Physical Exertion; Posture; Propranolol; Pulse | 1976 |
Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Labetalol; Leukocytes, Mononuclear; Male; Pindolol; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta | 1992 |
The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.
Topics: Adult; Analysis of Variance; Atenolol; Blood Flow Velocity; Female; Humans; Labetalol; Liver Cirrhosis; Male; Middle Aged; Portal System; Propranolol; Sympatholytics; Ultrasonography | 1991 |
Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study.
Topics: Adult; Blood Pressure; Cardiomegaly; Double-Blind Method; Echocardiography; Female; Heart Rate; Humans; Labetalol; Male; Middle Aged; Propranolol; Prospective Studies; Time Factors; Ventricular Function, Left | 1990 |
Effects of dilevalol, propranolol and placebo on retinal blood flow, blood pressure and heart rate: a double-blind study.
Topics: Blood Flow Velocity; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Labetalol; Propranolol; Randomized Controlled Trials as Topic; Reference Values; Retinal Vessels | 1990 |
Single dose pharmacokinetics and pharmacodynamics of oral oxazepam during concomitant administration of propranolol and labetalol.
Topics: Adult; Drug Interactions; Female; Humans; Labetalol; Male; Oxazepam; Propranolol; Psychomotor Performance; Reaction Time | 1990 |
Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Labetalol; Male; Physical Exertion; Pindolol; Propanolamines; Propranolol; Random Allocation | 1987 |
Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men.
Topics: Adrenergic beta-Antagonists; Adult; Cardiac Output; Heart; Heart Rate; Humans; Labetalol; Male; Oxygen Consumption; Physical Exertion; Propranolol; Pulmonary Gas Exchange; Respiration; Stroke Volume | 1989 |
Dilevalol compared with propranolol and placebo for systemic hypertension.
Topics: Aged; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Multicenter Studies as Topic; Propranolol; Random Allocation; Supination | 1989 |
Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Random Allocation | 1989 |
A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
Topics: Adolescent; Adult; Aged; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Multicenter Studies as Topic; Propranolol; Randomized Controlled Trials as Topic | 1989 |
Effects of two beta-antagonists (dilevalol and propranolol) on retinal blood flow: a double-blind placebo-controlled study.
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Labetalol; Male; Placebos; Propranolol; Randomized Controlled Trials as Topic; Reference Values; Regional Blood Flow; Retinal Vessels | 1989 |
Beta blockade by oral propranolol and labetalol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Double-Blind Method; Ethanolamines; Heart Rate; Humans; Injections, Intravenous; Isometric Contraction; Isoproterenol; Labetalol; Male; Propranolol; Random Allocation | 1985 |
Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Ethanolamines; Heart Rate; Humans; Labetalol; Male; Phenylephrine; Physical Exertion; Propanolamines; Propranolol; Time Factors | 1985 |
Beta blockade and intermittent claudication.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Gait; Hemodynamics; Humans; Hypertension; Intermittent Claudication; Labetalol; Leg; Male; Metoprolol; Middle Aged; Physical Exertion; Pindolol; Propranolol; Risk | 1985 |
Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Heart Rate; Humans; Isometric Contraction; Labetalol; Male; Prazosin; Propranolol; Random Allocation; Stress, Physiological | 1987 |
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents | 1988 |
[Effect of obsidan and labetalol on the course of myocardial infarction].
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Labetalol; Male; Middle Aged; Myocardial Infarction; Propranolol | 1988 |
Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
Topics: Aged; Black People; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol | 1987 |
Labetalol compared with propranolol in the treatment of black hypertensive patients.
Topics: Adolescent; Adult; Aged; Black People; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lipids; Male; Middle Aged; Propranolol; Prospective Studies; Random Allocation | 1987 |
Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Cold Temperature; Double-Blind Method; Heart Rate; Humans; Labetalol; Male; Physical Exertion; Posture; Propranolol; Stress, Physiological | 1986 |
Management of ventricular arrhythmias associated with mitral valve prolapse by combined alpha and beta blockade.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Exercise Test; Female; Humans; Isometric Contraction; Labetalol; Male; Middle Aged; Mitral Valve Prolapse; Propranolol; Valsalva Maneuver | 1986 |
The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.
Topics: Aged; Atenolol; Cardiac Output; Cardiovascular System; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Vascular Resistance | 1986 |
Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Heart Rate; Humans; Intermittent Claudication; Labetalol; Leg; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Vascular Resistance | 1985 |
A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
Topics: Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol | 1985 |
Propranolol versus labetalol: interesting differences in efficacy.
Topics: Adult; Aged; Black People; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Humans; Hypertension; Labetalol; Middle Aged; Propranolol | 1985 |
Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity.
Topics: Adolescent; Adult; Aged; Asthma; Clinical Trials as Topic; Drug Evaluation; Female; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Respiration | 1985 |
Monotherapy with labetalol compared with propranolol. Differential effects by race.
Topics: Adult; Aged; Black or African American; Bradycardia; Clinical Trials as Topic; Dizziness; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Humans; Hydrochlorothiazide; Labetalol; Male; Middle Aged; Propranolol; Sexual Dysfunction, Physiological; White People | 1985 |
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.
Topics: Adolescent; Adult; Atenolol; Blood Circulation; Ethanolamines; Female; Fingers; Humans; Hypertension; Labetalol; Male; Middle Aged; Plethysmography; Propranolol; Regional Blood Flow | 1985 |
Influence of labetalol, propranolol and practolol in patients with asthma.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Asthma; Bronchi; Ethanolamines; Female; Forced Expiratory Volume; Humans; Labetalol; Male; Middle Aged; Practolol; Propranolol | 1982 |
Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.
Topics: Adrenergic beta-Antagonists; Adult; Catecholamines; Epinephrine; Humans; Labetalol; Male; Metoprolol; Norepinephrine; Pindolol; Propranolol; Stress, Psychological | 1982 |
Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Ethanolamines; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Lung Volume Measurements; Metoprolol; Middle Aged; Propranolol | 1982 |
[Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Echocardiography; Heart; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Isometric Contraction; Labetalol; Male; Metoprolol; Middle Aged; Peak Expiratory Flow Rate; Propranolol | 1984 |
Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Ethanolamines; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation | 1983 |
Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.
Topics: Adult; Blood Pressure; Cardiac Output; Coronary Disease; Ethanolamines; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Physical Exertion; Propranolol; Random Allocation | 1982 |
Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Plasma Volume; Posture; Propranolol | 1980 |
Relation between ST-depression and chest pain in patients with coronary heart disease receiving no treatment and after beta-blockade and combined alpha-beta-blockade.
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Ethanolamines; Exercise Test; Heart Rate; Humans; Labetalol; Male; Middle Aged; Propranolol | 1981 |
Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Female; Half-Life; Humans; Hypertension; Kidney Diseases; Kinetics; Labetalol; Male; Middle Aged; Propranolol | 1982 |
Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Ethanolamines; Extremities; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Muscle Contraction; Plethysmography; Propranolol; Random Allocation; Regional Blood Flow; Vascular Resistance | 1982 |
Comparison of labetalol and propranolol in hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Time Factors | 1980 |
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Placebos; Propranolol | 1980 |
Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Time Factors | 1982 |
Renal haemodynamics after chronic treatment with labetalol and propranolol.
Topics: Adult; Aged; Blood Pressure; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Physical Exertion; Placebos; Propranolol; Renal Circulation | 1982 |
Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
Topics: Adult; Coronary Disease; Dose-Response Relationship, Drug; Ethanolamines; Heart Ventricles; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Physical Exertion; Propranolol | 1982 |
[Comparative study of labetolol and propranolol in patients with untreated hypertension].
Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol | 1981 |
The effect of labetalol and propranolol on the pressor response to sexual arousal in women.
Topics: Adult; Arousal; Blood Pressure; Ethanolamines; Female; Humans; Labetalol; Orgasm; Propranolol | 1981 |
Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.
Topics: Adult; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Exercise; Hemodynamics; Humans; Labetalol; Male; Norepinephrine; Propranolol; Regional Blood Flow; Renin; Rest | 1994 |
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Adult; Area Under Curve; Benzopyrans; Binding Sites; Bisoprolol; Blood Chemical Analysis; Blood Pressure; Cardiac Output; Chromatography, High Pressure Liquid; Ethanolamines; Female; Heart Rate; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Labetalol; Male; Nebivolol; Obesity; Propranolol; Regression Analysis; Sotalol; Stereoisomerism; Tissue Distribution | 1997 |
146 other study(ies) available for labetalol and propranolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cations; Cytochrome P-450 Enzyme System; Disease Models, Animal; Emulsions; Fats; Fatty Liver; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar | 2011 |
Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer.
Topics: Androgen Antagonists; Azepines; Cell Line; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Farnesyltranstransferase; Humans; Hydrophobic and Hydrophilic Interactions; Male; Models, Molecular; Prostatic Neoplasms; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Topics: Adrenergic beta-Antagonists; Amines; Ammonium Chloride; Antidepressive Agents, Tricyclic; Atorvastatin; Cell Line, Transformed; Diuretics; Hepatocytes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Lysosomes; Monensin; Nigericin; Propranolol; Pyrroles | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Monocarboxylic Acid Transporters; Structure-Activity Relationship; Symporters | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mice; Microsomes, Liver; Staphylococcal Infections; Thiazoles | 2018 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma; Propranolol | 1977 |
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Clonidine; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pheochromocytoma; Propranolol; Substance Withdrawal Syndrome | 1976 |
Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; Isoproterenol; Labetalol; Male; Myocardial Contraction; Phentolamine; Propranolol; Stroke Volume; Time Factors | 1978 |
Effects of the beta-receptor antagonists propranolol, oxprenolol and labetalol on human vascular smooth-muscle contraction.
Topics: Adrenergic beta-Antagonists; Arteries; Barium; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Muscle Contraction; Muscle, Smooth; Norepinephrine; Oxprenolol; Propranolol; Serotonin Antagonists | 1978 |
Hypotensive and vascular effects of labetalol in the normotensive rat and dog.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Blood Pressure; Dogs; Ethanolamines; Female; Femoral Artery; Heart Rate; Isoproterenol; Kidney; Labetalol; Male; Phentolamine; Propranolol; Rats; Regional Blood Flow; Vasomotor System | 1978 |
Reactivity of the cardiovascular system in the tetraplegic patient.
Topics: Adrenergic beta-Antagonists; Atropine; Blood Pressure; Electrocardiography; Guanethidine; Heart Rate; Hemodynamics; Humans; Labetalol; Male; Nitroglycerin; Phenoxybenzamine; Posture; Propranolol; Quadriplegia; Sympathetic Nervous System; Systole | 1979 |
Labetalol possesses beta-adrenoceptor agonist action on the rat isolated uterus.
Topics: Adrenergic beta-Agonists; Animals; Estrus; Ethanolamines; Female; In Vitro Techniques; Isoproterenol; Labetalol; Pregnancy; Propranolol; Rats; Uterine Contraction | 1979 |
The influence of calcium on the antilipolytic action of propranolol, timolol, labetalol, verapamil, procaine, and papaverine in rat adipocytes.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Animals; Calcium; In Vitro Techniques; Isoproterenol; Labetalol; Lipolysis; Male; Papaverine; Procaine; Propranolol; Rats; Timolol; Vasodilator Agents; Verapamil | 1979 |
Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Blood Pressure; Cats; Cocaine; Dogs; Drug Interactions; Ethanolamines; Female; Heart Rate; Labetalol; Male; Norepinephrine; Phenylephrine; Propranolol; Rats; Spinal Cord | 1975 |
Paroxysmal neurogenic hypertension and its prevention in patients with cervical spinal cord lesions.
Topics: Adult; Blood Pressure; Ethanolamines; Heart Rate; Humans; Hypertension; Labetalol; Middle Aged; Norepinephrine; Phenoxybenzamine; Propranolol; Pulse; Quadriplegia; Reflex, Abnormal | 1979 |
Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cocaine; Heart Rate; Labetalol; Male; Phentolamine; Prazosin; Propanolamines; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Saimiri; Yohimbine | 1992 |
Study of the glycogenolytic action of platelet activating factor in Tetrahymena pyriformis.
Topics: Animals; Atenolol; Calcium; Cyclic AMP; Glucose; Glycogen; Labetalol; Platelet Activating Factor; Propranolol; Tetrahymena pyriformis | 1992 |
Effect of oral dilevalol on forearm circulation in essential hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Female; Forearm; Heart Rate; Humans; Hypertension; Infusions, Intra-Arterial; Labetalol; Male; Middle Aged; Propranolol; Regional Blood Flow; Time Factors; Vascular Resistance | 1992 |
Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol.
Topics: Animals; Animals, Newborn; Biogenic Amines; Body Weight; Brain; Labetalol; Organ Size; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic | 1992 |
Response to beta-blockers in maternal and fetal rat hearts in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Female; Heart; Heart Rate; Isoproterenol; Labetalol; Metoprolol; Pregnancy; Pregnancy, Animal; Propranolol; Rats; Rats, Inbred Strains | 1991 |
The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cerebral Cortex; Dose-Response Relationship, Drug; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Labetalol; Male; Myocardium; Phenylephrine; Prazosin; Propranolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereoisomerism | 1991 |
Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Blood Pressure; Cardiomyopathies; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Isoproterenol; Labetalol; Male; Myocardial Contraction; Phenylephrine; Propanolamines; Propranolol | 1990 |
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susceptibility; Hypertension; Labetalol; Male; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium, Dietary | 1991 |
Effects of dilevalol on adrenoceptors in isolated cat arteries.
Topics: Animals; Arteries; Cats; Clonidine; Dinoprost; Electric Stimulation; Female; In Vitro Techniques; Labetalol; Male; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasoconstriction; Yohimbine | 1990 |
Inhibition of hypothalamic somatostatin release by beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Cells, Cultured; Clonidine; Growth Hormone; Hypothalamus; Labetalol; Male; Metoprolol; Ouabain; Pituitary Gland, Anterior; Propranolol; Rats; Rats, Inbred Strains; Somatostatin | 1990 |
Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Labetalol; Male; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1990 |
[The use of labetalol and propranolol in patients who have had a myocardial infarct].
Topics: Adult; Drug Evaluation; Exercise Test; Humans; Labetalol; Middle Aged; Myocardial Infarction; Physical Endurance; Propranolol; Recurrence | 1990 |
Cardiac alpha-adrenoceptors: postjunctional and prejunctional.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Animals; Calcium; Dioxanes; Dose-Response Relationship, Drug; Female; Heart Conduction System; Heart Rate; Idazoxan; In Vitro Techniques; Labetalol; Methoxamine; Myocardial Contraction; Myocardium; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; Verapamil | 1986 |
Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs.
Topics: Animals; Aorta; Blood Pressure; Compliance; Dogs; Female; Labetalol; Male; Pindolol; Propranolol; Ultrasonography | 1987 |
Effects of the antihypertensive dilevalol on aortic compliance in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Aorta, Abdominal; Compliance; Dogs; Female; Labetalol; Male; Propranolol; Vasodilator Agents | 1988 |
Cellular electrophysiology and beta-adrenergic-blocking activity of dilevalol, the R,R-isomer of labetalol, on isolated canine cardiac tissues.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Dogs; Electrophysiology; Heart; Heart Rate; In Vitro Techniques; Labetalol; Membrane Potentials; Microelectrodes; Muscles; Propranolol; Purkinje Fibers; Stereoisomerism | 1989 |
Effects of dilevalol on forearm circulation in essential hypertension.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Female; Forearm; Hemodynamics; Humans; Hypertension; Infusions, Intra-Arterial; Isoproterenol; Labetalol; Male; Middle Aged; Propranolol; Regional Blood Flow | 1989 |
Cocaine, pulmonary edema, and propranolol.
Topics: Animals; Cocaine; Humans; Labetalol; Propranolol; Pulmonary Edema | 1989 |
Non-resectable phaeochromocytoma: long term follow-up.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Aortography; Female; Humans; Labetalol; Phenoxybenzamine; Pheochromocytoma; Propranolol; Time Factors; Tomography, X-Ray Computed; Venae Cavae | 1989 |
[Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Circadian Rhythm; Cold Temperature; Drug Therapy, Combination; Humans; Hypertension; Indoramin; Labetalol; Prazosin; Propranolol | 1985 |
Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Autonomic Nervous System; Blood Pressure; Ethanolamines; Heart Rate; Isoproterenol; Labetalol; Male; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1985 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Pindolol; Platelet Aggregation; Prazosin; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Guinea Pigs; Heart Rate; In Vitro Techniques; Labetalol; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propranolol; Rats; Rats, Inbred Strains; Stereoisomerism; Trachea | 1985 |
[Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Labetalol; Oxprenolol; Oxygen Consumption; Phentolamine; Physical Endurance; Physical Exertion; Pindolol; Propranolol; Time Factors | 1986 |
Electrophysiological effects of amosulalol, a new alpha- and beta-adrenoceptor blocker, in isolated rabbit papillary muscles.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Electric Stimulation; Ethanolamines; Female; Heart; In Vitro Techniques; Kinetics; Labetalol; Male; Papillary Muscles; Prazosin; Propranolol; Rabbits; Time Factors | 1986 |
Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Dinoprost; Dose-Response Relationship, Drug; Drug Synergism; Endothelium; Labetalol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Propanolamines; Propranolol; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Pyridines; Rats; Rats, Inbred Strains; Spiro Compounds; Timolol; Vasodilation | 1986 |
Labetalol protects against the potentiation by propranolol of the bronchospasm to norepinephrine in guinea-pigs.
Topics: Adrenergic alpha-Agonists; Animals; Bronchial Spasm; Drug Interactions; Guinea Pigs; Labetalol; Male; Norepinephrine; Propranolol | 1987 |
Lipophilic beta-adrenoceptor antagonists stimulate cholesterol biosynthesis in human skin fibroblasts.
Topics: Adrenergic beta-Antagonists; Cholesterol; Fibroblasts; Humans; Hydroxymethylglutaryl CoA Reductases; Labetalol; Metoprolol; Pindolol; Propanolamines; Propranolol; Skin; Stereoisomerism | 1987 |
Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.
Topics: Adrenergic alpha-Antagonists; Animals; Bronchi; Guinea Pigs; Histamine; Labetalol; Lung; Male; Neural Conduction; Plethysmography; Prazosin; Propranolol; Respiration | 1987 |
[The effect of dilevalol in histamine-induced airway constriction in guinea pigs].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Airway Resistance; Animals; Guinea Pigs; Histamine; Labetalol; Propranolol; Respiratory Hypersensitivity; Sympathomimetics | 1987 |
Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Female; Humans; In Vitro Techniques; Labetalol; Maternal-Fetal Exchange; Placenta; Pregnancy; Propanolamines; Propranolol; Timolol | 1988 |
Beta blockers inhibit fetal thromboxane A2 production in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Labetalol; Metoprolol; Pregnancy; Propranolol; Thromboxane A2 | 1988 |
[Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Placebos; Propranolol | 1988 |
The effects of vasoactive agents on the proliferation of vascular smooth muscle cells grown in vitro.
Topics: Amiloride; Animals; Captopril; Cell Division; Cells, Cultured; Chlorpromazine; In Vitro Techniques; Labetalol; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Norepinephrine; Propranolol; Quinazolines; Rats; Sulfonamides | 1988 |
[Arterial hypertension secondary to Guillain-Barré syndrome. Treatment with a labetalol and chlorpromazine combination. Apropos of a case].
Topics: Aged; Chlorpromazine; Drug Therapy, Combination; Female; Humans; Hypertension; Labetalol; Nitroprusside; Polyradiculoneuropathy; Propranolol | 1988 |
The role of catecholamines and glucagon on serum and liver metallothionein response to restraint stress.
Topics: Animals; Catecholamines; Glucagon; Labetalol; Liver; Male; Metallothionein; Propranolol; Rats; Rats, Inbred Strains; Restraint, Physical; Zinc | 1987 |
Modulation of circadian rhythms in antibody and cell-mediated immunity by chemical sympathectomy.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Circadian Rhythm; Immunity, Cellular; Labetalol; Male; Propranolol; Rats; Rats, Inbred Strains; Sympathectomy, Chemical | 1987 |
[Definition and significance of the area at risk in myocardial infarct and the ischemic border zone in acute myocardial infarct].
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Electrolytes; Energy Metabolism; Fluorocarbons; Hemodilution; Labetalol; Myocardial Infarction; Myocardium; Oxygen Consumption; Oxygen Inhalation Therapy; Phosphates; Propranolol; Risk | 1986 |
Effects of labetalol on renin release from rat kidney cortical slices.
Topics: Animals; In Vitro Techniques; Isoproterenol; Kidney Cortex; Labetalol; Male; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Renin | 1986 |
Effects of labetalol on in vitro preparations of the trachea and lung strips and on ventilation overflow in vivo in guinea pigs.
Topics: Acetylcholine; Aerosols; Animals; Diphenhydramine; Female; Guinea Pigs; Histamine; In Vitro Techniques; Labetalol; Lung; Male; Phentolamine; Propranolol; Respiration; Trachea | 1987 |
Adrenoceptor blocking drugs and cold feet in intermittent claudication.
Topics: Aged; Foot; Humans; Hypertension; Intermittent Claudication; Labetalol; Male; Middle Aged; Propranolol; Raynaud Disease; Skin Temperature | 1986 |
Postmarketing comparison of labetalol and propranolol in hypertensive patients.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Product Surveillance, Postmarketing; Propranolol | 1986 |
The effect of ageing and disease on tear constituents.
Topics: Adult; Aged; Aging; Blepharitis; Ceruloplasmin; Eyelid Diseases; Humans; Immunoglobulin A; Immunoglobulin G; Keratoconjunctivitis; Labetalol; Lactoferrin; Middle Aged; Muramidase; Pemphigoid, Bullous; Practolol; Propranolol; Tears; Timolol; Xerophthalmia | 1985 |
Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Atenolol; Collagen; Drug Synergism; Epoprostenol; Humans; Labetalol; Pindolol; Platelet Aggregation; Propranolol; Solubility; Sympatholytics | 1985 |
Hypertensive emergencies.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroprusside; Propranolol; Risk; Trimethaphan | 1985 |
[Cholinergic antagonism by beta-blockers. I. Spectrum of interactions].
Topics: Abdominal Muscles; Acetylcholine; Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; Ileum; Isoproterenol; Labetalol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Receptors, Cholinergic; Sotalol | 1980 |
[Cholinergic antagonism by beta-blockers. II. Sequence of interactions and final steady state effects].
Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Drug Interactions; Guinea Pigs; Heart; Isoproterenol; Labetalol; Male; Metoprolol; Practolol; Propranolol; Receptors, Cholinergic; Time Factors | 1980 |
Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Chemical Phenomena; Chemistry; Dogs; Ethanolamines; Labetalol; Muscle, Smooth, Vascular; Phentolamine; Propranolol; Salicylamides; Stereoisomerism; Structure-Activity Relationship | 1982 |
[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Echocardiography; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
Impairment of physical performance after treatment with beta blockers and alpha blockers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alprenolol; Heart Rate; Humans; Hydrochlorothiazide; Labetalol; Male; Metoprolol; Physical Exertion; Pindolol; Prazosin; Propranolol; Running | 1984 |
[Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Ion Channels; Labetalol; Oxprenolol; Pindolol; Propranolol; Rana ridibunda | 1984 |
Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Ethanolamines; Hypertension; In Vitro Techniques; Labetalol; Male; Norepinephrine; Phentolamine; Propranolol; Rats; Rats, Inbred SHR; Stereoisomerism; Time Factors | 1984 |
Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
Topics: Animals; Blood Pressure; Ethanolamines; Heart Rate; Intraocular Pressure; Labetalol; Male; Phentolamine; Propranolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1981 |
Effect of labetalol and propranolol on human cutaneous vasoconstrictor response to adrenaline.
Topics: Adult; Epinephrine; Ethanolamines; Half-Life; Humans; Iodine Radioisotopes; Labetalol; Male; Propranolol; Skin; Temperature; Vasoconstriction | 1984 |
Effects of labetalol and propranolol on responses to adrenaline infusion in healthy volunteers.
Topics: Adult; Blood Pressure; Epinephrine; Ethanolamines; Heart Rate; Humans; Infusions, Parenteral; Labetalol; Male; Propranolol; Pulse | 1984 |
Cold pressor test: a comparative study between labetalol and propranolol.
Topics: Blood Pressure; Blood Pressure Determination; Cold Temperature; Ethanolamines; Female; Heart Rate; Humans; Labetalol; Male; Propranolol | 1983 |
Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
Topics: Aged; Cardiac Output; Dose-Response Relationship, Drug; Ethanolamines; Heart Rate; Hemodynamics; Humans; Labetalol; Middle Aged; Myocardial Infarction; Propranolol; Random Allocation; Stroke Volume; Vascular Resistance | 1984 |
The in vitro effect of hypotensive agents on the affinity of haemoglobin for oxygen.
Topics: Erythrocytes; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Labetalol; Nitroprusside; Oxyhemoglobins; Pentolinium Tartrate; Propranolol; Trimethaphan; Vasodilator Agents | 1984 |
Adrenaline induced dysrhythmias: comparison of the antidysrhythmic effect of labetalol with propranolol during normocarbia and hypercarbia in halothane anaesthetized cats.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Dioxide; Cats; Epinephrine; Ethanolamines; Halothane; Labetalol; Propranolol | 1980 |
[Vasospastic angina pectoris complicated by ventricular fibrillation during treatment with propranolol and labetalol].
Topics: Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Ethanolamines; Female; Humans; Labetalol; Middle Aged; Propranolol; Ventricular Fibrillation | 1983 |
Ocular hypotensive action of labetalol in rabbit and human eyes.
Topics: Animals; Dose-Response Relationship, Drug; Ethanolamines; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Labetalol; Male; Ophthalmic Solutions; Pilocarpine; Propranolol; Rabbits; Timolol | 1981 |
The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.
Topics: Adult; Antipyrine; Atenolol; Drug Interactions; Female; Half-Life; Humans; Kinetics; Labetalol; Male; Propranolol; Sympatholytics | 1982 |
The effect of different antihypertensive therapies on plasma lipids.
Topics: Aged; Bendroflumethiazide; Cholesterol; Ethanolamines; Female; Humans; Hypertension; Labetalol; Lipoproteins, HDL; Male; Middle Aged; Propranolol; Triglycerides | 1982 |
Aortic rigidity and plasma catecholamines in essential hypertensive patients.
Topics: Adult; Aged; Aorta, Thoracic; Blood Pressure; Compliance; Epinephrine; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Propranolol; Sympathetic Nervous System | 1982 |
Adrenergic activity in systolic hypertension.
Topics: Aged; Epinephrine; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Norepinephrine; Phentolamine; Propranolol; Systole | 1982 |
Effects of Dl- and l-propranolol, labetalol, and phentolamine on rabbit iris blood flow determined by hydrogen clearance method.
Topics: Animals; Blood Pressure; Blood Volume Determination; Ethanolamines; Iris; Isomerism; Labetalol; Phentolamine; Propranolol; Rabbits; Regional Blood Flow | 1982 |
[Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Propranolol | 1981 |
Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Topics: Adult; Ethanolamines; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney; Labetalol; Male; Physical Exertion; Propranolol; Rest | 1980 |
Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Topics: Blood Pressure; Ethanolamines; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Labetalol; Male; Physical Exertion; Propranolol; Regional Blood Flow | 1980 |
Comparison of labetalol and propranolol in treatment of hypertension.
Topics: Blood Pressure; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Propranolol; Time Factors | 1980 |
Sympathetic hyperreflexia in tetraplegics. The value of systolic time intervals in assessing drug effects.
Topics: Adult; Guanethidine; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Contraction; Phenoxybenzamine; Propranolol; Quadriplegia; Reflex, Abnormal; Systole | 1980 |
The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Fatal Outcome; Female; Humans; Labetalol; Male; Pheochromocytoma; Propranolol | 1995 |
Effects of beta-adrenoceptor antagonists on portal vein hypertension and ethanol-induced gastric mucosal damage in rats.
Topics: Adrenergic beta-Antagonists; Animals; Ethanol; Gastric Mucosa; Hemodynamics; Hypertension, Portal; Labetalol; Male; Metoprolol; Nadolol; Pindolol; Propranolol; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1994 |
Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Circadian Rhythm; Clonidine; Felodipine; Heart Rate; Hypertension; Labetalol; Male; Metoprolol; Oxazoles; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rilmenidine; Thiophenes | 1993 |
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.
Topics: Adipose Tissue; Adult; Analysis of Variance; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Ethanol; Female; Glycerol; Humans; Hydralazine; Kinetics; Labetalol; Lipid Mobilization; Male; Nitroprusside; Propranolol; Receptors, Adrenergic, alpha; Time Factors; Yohimbine | 1993 |
Determination of propranolol, labetalol and clenbuterol in rat brain by high-performance liquid chromatography.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Clenbuterol; Labetalol; Male; Propranolol; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1993 |
The regulation of total creatine content in a myoblast cell line.
Topics: Animals; Atenolol; Bucladesine; Butoxamine; Cell Line; Clenbuterol; Creatine; Energy Metabolism; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Labetalol; Methoxamine; Mice; Muscle, Skeletal; Norepinephrine; Phentolamine; Propranolol; Sodium; Triiodothyronine | 1996 |
Stereoselective interaction of drug enantiomers with human serum transferrin in capillary zone electrophoresis.
Topics: Bupivacaine; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Labetalol; Pharmaceutical Preparations; Promethazine; Propranolol; Stereoisomerism; Transferrin | 1996 |
Study of propranolol and its related adrenoceptor antagonists on changes of gastric electrical parameters induced by ethanol in rats.
Topics: Adrenergic beta-Antagonists; Animals; Butoxamine; Dose-Response Relationship, Drug; Electric Conductivity; Electrophysiology; Ethanol; Gastric Mucosa; Labetalol; Male; Metoprolol; Nadolol; Propranolol; Rats; Rats, Sprague-Dawley | 1999 |
The effects of atropine and adrenergic antagonists on behavioral arousal in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arousal; Atropine; Drug Synergism; Labetalol; Motor Activity; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley | 2000 |
Divergent effects of different beta-blocking agents on endothelium-dependent vasodilatation in the human forearm.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Blood Pressure; Diclofenac; Endothelium, Vascular; Female; Forearm; Heart Rate; Humans; Injections, Intra-Arterial; Labetalol; Male; Methacholine Chloride; Nitroprusside; Plethysmography; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Muscarinic; Vasodilation; Vasodilator Agents | 2000 |
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Benzaldehydes; Blood Pressure; Cardiovascular Agents; Depression, Chemical; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Heart Rate; Isoproterenol; Labetalol; Mecamylamine; Models, Animal; Muscle, Smooth, Vascular; Myocardial Contraction; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Regression Analysis; Stimulation, Chemical; Vasodilator Agents | 2000 |
Electrocardiographic changes associated with beta-blocker toxicity.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Electrocardiography; Female; Heart Rate; Humans; Labetalol; Male; Middle Aged; Poison Control Centers; Propranolol; Prospective Studies | 2002 |
Effect of beta-adrenergic antagonists on bioluminescence control in three species of brittlestars (Echinodermata: Ophiuroidea).
Topics: Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Echinodermata; Epinephrine; Labetalol; Luminescence; Potassium Chloride; Propranolol; Species Specificity | 2004 |
Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
Topics: Adrenergic beta-Antagonists; Animals; Electrocardiography; Isoproterenol; Labetalol; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Partial Thromboplastin Time; Propranolol; Rabbits; Vitamin E | 2004 |
Modeling the electrophoretic mobility of beta-blockers in capillary electrophoresis using artificial neural networks.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrolytes; Electrophoresis, Capillary; Electrophoretic Mobility Shift Assay; Labetalol; Models, Chemical; Neural Networks, Computer; Pharmaceutical Preparations; Practolol; Predictive Value of Tests; Propranolol; Solvents; Technology, Pharmaceutical; Timolol | 2005 |
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Brain Chemistry; Catecholamines; Cytokines; Electroshock; Immunohistochemistry; Labetalol; Male; Prazosin; Propranolol; Rats; Rats, Inbred F344; Stress, Psychological; Tyrosine 3-Monooxygenase | 2005 |
Simultaneous determination of beta-blockers in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Chromatography, Liquid; Humans; Labetalol; Linear Models; Metoprolol; Pindolol; Propranolol; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
Microcalorimetric and zeta potential study on binding of drugs on liposomes.
Topics: Algorithms; Alprenolol; Binding Sites; Binding, Competitive; Calorimetry; Entropy; Kinetics; Labetalol; Liposomes; Models, Chemical; Molecular Structure; Pharmaceutical Preparations; Phosphatidylcholines; Phosphatidylglycerols; Propranolol; Tetracaine; Thermodynamics | 2010 |
Kinetic capillary electrophoresis with mass-spectrometry detection (KCE-MS) facilitates label-free solution-based kinetic analysis of protein-small molecule binding.
Topics: Alprenolol; Electrophoresis, Capillary; Kinetics; Labetalol; Mass Spectrometry; Orosomucoid; Pindolol; Propranolol; Protein Binding; Proteins; Small Molecule Libraries | 2011 |
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Atenolol; Cell Membrane Permeability; Cytochrome P-450 Enzyme System; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heart Failure; Labetalol; Linear Models; Liver; Liver Cirrhosis; Liver Diseases; Male; Metabolic Clearance Rate; Metoprolol; Microsomes, Liver; Models, Biological; Necrosis; Nonlinear Dynamics; Perfusion; Propranolol; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
To block or not to block? That is the question.
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Female; Humans; Labetalol; Male; Nebivolol; Propranolol; Radial Artery; Vasodilation; Vasodilator Agents | 2015 |
Labetalol, nebivolol, and propranolol relax human radial artery used as coronary bypass graft.
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Labetalol; Male; Middle Aged; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Propranolol; Radial Artery; Vasodilation; Vasodilator Agents | 2015 |
The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.
Topics: Acrylamides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Body Temperature; Body Temperature Regulation; Bridged Bicyclo Compounds, Heterocyclic; Fever; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Labetalol; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Prazosin; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Sympathetic Nervous System; Telemetry; TRPV Cation Channels | 2015 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; California; Cohort Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus; Eclampsia; Female; Gestational Age; Heart Defects, Congenital; Heart Failure; Humans; Hyperlipidemias; Hypertension; Labetalol; Logistic Models; Metoprolol; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Propranolol; Retrospective Studies; Risk; Risk Factors | 2017 |
Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome?
Topics: Carvedilol; Humans; Labetalol; Metoprolol; Propranolol; Takotsubo Cardiomyopathy | 2018 |
Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?
Topics: Carvedilol; Humans; Labetalol; Metoprolol; Propranolol; Takotsubo Cardiomyopathy | 2018 |
Calculating Kinetic Rates and Membrane Permeability from Biased Simulations.
Topics: Cell Membrane Permeability; Chlorpromazine; Desipramine; Domperidone; Kinetics; Labetalol; Lipid Bilayers; Loperamide; Molecular Dynamics Simulation; Molecular Structure; Propranolol; Thermodynamics; Verapamil | 2018 |
Beta-blocker subtypes and risk of low birth weight in newborns.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Male; Metoprolol; Pregnancy; Prevalence; Propranolol; Retrospective Studies | 2018 |
Use of a non-hepatic cell line highlights limitations associated with cell-based assessment of metabolically induced toxicity.
Topics: Activation, Metabolic; Cell Proliferation; Cell Survival; Chlorpromazine; Cytochrome P-450 CYP3A; Epithelial Cells; HEK293 Cells; Humans; Labetalol; Propranolol; Risk Assessment; Rosiglitazone; Substrate Specificity; Toxicity Tests | 2020 |
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |